Leejee Han Suh, MD - CUIMC/Edward S Harkness Eye Institute

Call
Website

Advertisement

Photos

622 W 168th St Ste 3
New York, NY 10032
+1 (212) 305-9535
https://doctors.columbia.edu
Leejee H. Suh, M.D., the Miranda Wong Tang Professor of Ophthalmology, is the Director of the Cornea Service at Columbia University's Edward S. Harkness Eye Institute. She also heads the Laser Vision Center. Her surgical specialties include femtosecond laser-assisted cataract surgery, phacoemulsification cataract surgery, LASIK (Laser Assisted In-Situ Keratomileusis), PRK (Photorefractive Keratectomy), PTK (Phototherapeutic Keratectomy), and full and partial corneal transplantation.She received her undergraduate degree from the Massachusetts Institute of Technology (M.I.T.) and her medical degree from the New York University (N.Y.U.) School of Medicine. She completed her ophthalmology residency at the Wilmer Eye Institute at the Johns Hopkins Medical Center and received her fellowship training at the Bascom Palmer Eye Institute at the University of Miami Hospitals, where she was a faculty member in the Division of Cornea and Refractive Surgery.Dr. Suh brings to Columbia her experience from the top ophthalmological institutions in the country, with an extensive background in cataract, corneal, and refractive surgery. She has authored numerous peer-reviewed articles and book chapters on corneal conditions and is active in clinical research. Her clinical research interests are in keratoconus research and treatments, namely Corneal Collagen Crosslinking. She has been the Principal Investigator for the Corneal Collagen Crosslinking trial for the treatment of keratoconus and post-refractive surgery ectasia at Columbia University. For her work in keratoconus, Dr. Suh has been named a Top Doctor for the National Keratoconus Foundation (NKCF). She was instrumental in the early studies of a newer type of partial corneal transplantation, called endothelial keratoplasty, which includes Descemets Stripping Automated Endothelial Keratoplasty (DSAEK) and Descemets Membrane Endothelial Keratoplasty (DMEK), both of which have dramatically changed the face of surgical treatments for corneal diseases. As a cornea-refractive surgeon by training, she is an expert in the latest in cataract surgery called femtosecond-laser assisted cataract surgery, in which a femtosecond laser can make precise and customized corneal and lens incisions for cataract surgery, which is combined with implantation of standard monofocal, toric, and multifocal/trifocal intraocular lens implants. With her extensive experience in corneal surgery, she is also an expert in laser vision correction and keratorefractive surgery (LASIK, PRK, and PTK).Dr. Suh has been certified by the American Board of Ophthalmology and is a fellow of the American Academy of Ophthalmology. She has presented at the annual meetings of the American Academy of Ophthalmology (AAO), Association for Research in Vision and Ophthalmology (ARVO), Asian-Pacific Association for Cataract and Refractive Surgeons (APACRS), and the American Society of Cataract and Refractive Surgery (ASCRS). She is an active reviewer for such journals as Ophthalmology, American Journal of Ophthalmology, Archives of Ophthalmology, Ocular Immunology and Inflammation, Eye, and Cornea. Dr. Suh continues to lecture nationally and internationally on her research and experience.

Also at this address

Owner verified
See a problem?

You might also like

Scott E Brodie, MD - CUIMC/Edward S. Harkness Eye Institute
Internal medicine practitioners

Scott E Brodie, MD - CUIMC/Edward S. Harkness Eye Institute

Scott E. Brodie, MD, Ph.D., is a Professor of Clinical Ophthalmology and Attending Ophthalmologist in the Department of Ophthalmology. He is an internationally known clinician-scientist, and a leader in the use of electrophysiologic techniques for diagnosing of visual impairments in children and adults. Dr. Brodie is a graduate of the combined MD-PhD program at Weill-Cornell Medical College and The Rockefeller University in New York. He completed his PhD in retinal physiology in the laboratory of Nobel Laureate H. K. Hartline, under the supervision of Dr. Floyd Ratliff and Prof. Bruce Knight. He completed a medical internship and residency training in ophthalmology at The New York Hospital, and subsequently received fellowship training in medical retinal disorders and clinical electrophysiology of vision at New York University and Bellevue Hospital under the supervision of Dr. Ronald Carr, with support as a John Kluge Fellow of the Retinitis Pigmentosa Foundation. He is a fellow of the American Academy of Ophthalmology, and a member of the Association for Research in Vision and Ophthalmology, the International Society for Clinical Electrophysiology of Vision, the International Society for Genetic Eye Disease, and the Ophthalmic Genetics Study Club. He is a Fellow of the Association for Research in Vision and Ophthalmology, and has been honored with the Senior Achievement Award of the American Academy of Ophthalmology, as well as the Academys Secretariat Award for Education. Dr. Brodies research centers on improving methodologies for electrophysiologic testing, and descriptions of novel findings in patients with inherited and metabolic retinal disorders. He has been a key member of the teams which have introduced important new therapies, including enzyme-replacement therapy for Fabry disease, and intra-arterial chemotherapy for retinoblastoma, which has increased the rate of salvage of diseased eyes in the most severely affected patients from 20% to 80%. Dr. Brodie has published extensively on electrophysiology and retinal disorders. He has a particular interest in clinical optics, and has served as Chair of the Editorial committee for the American Academy of Ophthalmologys Basic and Clinical Science Course on Clinical Optics for the past eight years. In his spare time, he enjoys reading mathematics, and playing the oboe in local orchestras and chamber groups.
Brian Peter Marr, MD - CUIMC/Edward S Harkness Eye Institute
Internal medicine practitioners

Brian Peter Marr, MD - CUIMC/Edward S Harkness Eye Institute

Brian Marr, MD heads the Ophthalmic Oncology Service at the Harkness Eye Institute. He has comprehensive experience in the diagnosis, treatment, and management of ocular tumors including intraocular tumor resection, laser, radiation, and chemotherapy procedures. He has helped devise thousands of complex treatments for tumors of the eye, eyelid, orbit, and conjunctiva for his adult, children, and infant patients. Currently, Dr. Marr is a collaborator on a Columbia University clinical trial for a first-of-its-kind, new class of drug treatment for uveal melanoma.Dr. Marr is a board-certified ophthalmologist whose work has centered around ophthalmic oncology since 2000. One of the very few ocular oncologists trained in all aspects of eye cancer, Dr. Marr's clinical experience in treating these diseases is among the most extensive in the United States. His interest and experience in ophthalmic oncology began during an eight-year tenure in the Ocular Oncology Service at the Wills Eye Hospital in Philadelphia. There, he gained extensive experience treating intraocular tumors, and tumors of the eyelid, orbit, and conjunctiva in children and adults. It was there that Dr. Marr developed and improved many surgical procedures used to cure cancers of the eye, successfully treated thousands of patients, and helped their families though their battle with eye cancer. Next, Dr. Marr moved on to Memorial Sloan Kettering Cancer Center, where he remain for nine years, starting in 2008.Dr. Marr has some of the greatest experience with intra-arterial chemotherapy for treating retinoblastoma in the country, if not the world, as well as all other forms of retinoblastoma treatment. He has been a key member of many multidisciplinary surgical teams, treating advanced skull base tumors and complex facial skin lesions. He has developed a strong belief and treatment philosophy that the best research be used to help his patients, rather than his best patients be used to help his research. The field of ophthalmic oncology encompasses many rare conditions and his experience helps his patients get the best care and results as quickly as possible. Dr. Marr lectures and consults across the US and abroad, and has authored numerous research articles in the field of ocular oncology. He is the principal investigator in a first-in-class drug study for treating primary uveal melanoma, in an international, multi-center trial. He also volunteers his medical expertise in underserviced parts of the world, such as Nigeria and Indonesia, and has helped train physicians in more than 20 countries. Dr. Marrs efforts as a contributor to ongoing education in ocular oncology have been recognized by the American Academy of Ophthalmology, where he now serves as chief editor of the Academys Oncology and Pathologys One network.
Aliaa Hamed Abdelhakim, MD - CUIMC/Edward S Harkness Eye Institute
Internal medicine practitioners

Aliaa Hamed Abdelhakim, MD - CUIMC/Edward S Harkness Eye Institute

Aliaa Abdelhakim, MD, PhD is Assistant Professor in Ophthalmology at Columbia University Irving Medical Center and Assistant Attending in NewYork Presbyterian Hospital.Dr. Abdelhakim is a board-certified ophthalmologist and retina specialist at the Harkness Eye Institute. She also completed her fellowship in Medical Genetics and Genomics at the Morgan Stanley Children's Hospital of New York. Dr. Abdelhakim specializes in conditions of the retina, as well as patients with genetic conditions affecting the eyes.Dr. Abdelhakim completed her medical school training at Columbia University Vagelos College of Physicians and Surgeons, followed by an ophthalmology residency and vitreoretinal surgical fellowship at the Columbia University Harkness Eye Institute, the latter under the mentorship of Tongalp Tezel, MD. Prior to her medical training, she completed a Ph.D. in biochemistry and molecular biology at the Massachusetts Institute of Technology, and a postdoctoral fellowship in Structural and Cell Biology at Harvard Medical School/ Childrens Hospital Boston.Dr. Abdelhakim has won numerous awards as a clinician and researcher, including Alpha Omega Alpha and the Heed Ophthalmic Fellowship. She was recently named the inaugural Burch-Chang Scholar, recognizing her as one of the rising research talents in ophthalmology.
United States›New York›New York›Leejee Han Suh, MD - CUIMC/Edward S Harkness Eye Institute

Partial Data by Infogroup (c) 2025. All rights reserved.

Advertisement